Silverglade leaves CSPI
This article was originally published in The Tan Sheet
After more than 25 years with the Center for Science in the Public Interest, Bruce Silverglade resigns as the advocacy group's director of legal affairs and joins the law firm Olsson Frank Weeda Terman Bode Matz as a principal Nov. 1. While at CSPI, Silverglade led the bipartisan campaign to enact the Nutrition Labeling and Education Act of 1990 and recently worked with FDA to identify and enforce against firms that make inappropriately aggressive nutrient and health claims that could make foods unapproved drugs (1"The Tan Sheet" March 8, 2010)
You may also be interested in...
A spate of FDA warning letters detailing labeling violations and an open letter from Commissioner Margaret Hamburg largely quash any hopes the food industry might have had for regulatory latitude to make aggressive health claims
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.